FDA label
What is Xopenex HFA used for?
Xopenex HFA contains levalbuterol. The FDA-approved uses below are quoted from the Indications and Usage section of its DailyMed label.
Source: DailyMed SPL label file dated 2026-10-23. Publisher page
The FDA label for Xopenex HFA lists this use: Bronchospasm.
Run it in Rivvi
Which 2027 plans near you dropped or restricted Xopenex HFA?
Tier changes and new prior auth, step therapy or quantity limits, plan by plan.
Free to start. Opens Rivvi, the AI workspace for healthcare teams.
Xopenex HFA, aerosol, metered
Indications and Usage, quoted from the label by Lupin Pharmaceuticals, Inc. (NDA021730). Cross-references to other label sections are left out.
Bronchospasm
XOPENEX HFA is indicated for the treatment or prevention of bronchospasm in adults, adolescents, and children 4 years of age and older with reversible obstructive airway disease.
Source: DailyMed label, set id 70a35706-d7a8-4a48-98c6-1cab1c42fe8d, version 3, effective June 2, 2025. NDC 27437-056, one of 1 listing for this product.
Questions
What is Xopenex HFA used for?
The FDA label for Xopenex HFA lists this use: Bronchospasm.
What drug class is Xopenex HFA?
FDA lists levalbuterol in the beta2-Adrenergic Agonist established pharmacologic class.
Does this page cover off-label uses or dosing?
No. This page shows only the Indications and Usage section of the FDA label. Ask a pharmacist or prescriber about dosing.
More on Xopenex HFA
- Is Xopenex HFA a controlled substance?Federal schedule
- Generic for Xopenex HFAFDA Orange Book
- What is Levalbuterol used for?FDA label uses
- Is Levalbuterol a controlled substance?Federal schedule
- Generic for XopenexFDA Orange Book
- Beta2-Adrenergic Agonists listFDA drug class
- NDC 27437-056Xopenex HFA NDC record